Goldman Sachs Group Inc Boston Scientific Corp Transaction History

Goldman Sachs Group Inc

$613 Billion
Q4 2024

A detailed history of Goldman Sachs Group Inc transactions in Boston Scientific Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 12,885,308 shares of BSX stock, worth $1.32 Billion. This represents 0.19% of its overall portfolio holdings.

Number of Shares

12,885,308

Previous 13,242,537 2.7%

Holding current value

$1.32 Billion

Previous $1.11 Billion 3.71%

% of portfolio

0.19%

Previous 0.18%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$83.62 - $91.5 $29.9 Million - $32.7 Million	-357,229 Reduced 2.7%	12,885,308 $1.15 Billion
Q3 2024 Nov 14, 2024	SELL	$72.96 - $84.0 $13.6 Million - $15.6 Million	-186,272 Reduced 1.39%	13,242,537 $1.11 Billion
Q2 2024 Aug 13, 2024	SELL	$67.33 - $77.71 $83.3 Million - $96.2 Million	-1,237,659 Reduced 8.44%	13,428,809 $1.03 Billion
Q1 2024 May 15, 2024	SELL	$57.6 - $68.62 $78.3 Million - $93.3 Million	-1,360,025 Reduced 8.49%	14,666,468 $1 Billion
Q4 2023 Feb 13, 2024	SELL	$48.64 - $57.81 $28.8 Million - $34.2 Million	-591,845 Reduced 3.56%	16,026,493 $926 Million
Q3 2023 May 14, 2024	BUY	$50.19 - $54.68 $29.7 Million - $32.4 Million	591,845 Added 3.69%	16,618,338 $877 Million
Q3 2023 Nov 14, 2023	SELL	$50.19 - $54.68 $108 Million - $118 Million	-2,152,877 Reduced 11.47%	16,618,338 $877 Million
Q2 2023 May 14, 2024	BUY	$49.72 - $54.64 $44.6 Million - $49 Million	897,259 Added 5.02%	18,771,215 $1.02 Billion
Q2 2023 Aug 14, 2023	BUY	$49.72 - $54.64 $44.6 Million - $49 Million	897,259 Added 5.02%	18,771,215 $1.02 Billion
Q1 2023 May 14, 2024	SELL	$45.09 - $50.03 $3.9 Million - $4.33 Million	-86,573 Reduced 0.48%	17,873,956 $894 Million
Q1 2023 May 11, 2023	SELL	$45.09 - $50.03 $3.9 Million - $4.33 Million	-86,573 Reduced 0.48%	17,873,956 $894 Million
Q4 2022 May 14, 2024	SELL	$39.56 - $47.22 $59.5 Million - $71 Million	-1,504,520 Reduced 7.73%	17,960,529 $831 Million
Q4 2022 Feb 13, 2023	SELL	$39.56 - $47.22 $59.5 Million - $71 Million	-1,504,520 Reduced 7.73%	17,960,529 $831 Million
Q3 2022 May 14, 2024	BUY	$36.71 - $109.66 $186 Million - $555 Million	5,062,939 Added 35.15%	19,465,049 $754 Million
Q3 2022 Nov 10, 2022	BUY	$36.71 - $109.66 $186 Million - $555 Million	5,062,939 Added 35.15%	19,465,049 $754 Million
Q2 2022 May 14, 2024	SELL	$35.24 - $47.1 $57.2 Million - $76.5 Million	-1,624,383 Reduced 10.14%	14,402,110 $537 Million
Q2 2022 Aug 15, 2022	SELL	$35.24 - $47.1 $121 Million - $162 Million	-3,443,340 Reduced 19.3%	14,402,110 $537 Million
Q1 2022 May 16, 2022	SELL	$40.9 - $45.1 $45.4 Million - $50.1 Million	-1,110,661 Reduced 5.86%	17,845,450 $790 Million
Q4 2021 Feb 14, 2022	BUY	$38.07 - $44.87 $102 Million - $120 Million	2,669,063 Added 16.39%	18,956,111 $805 Million
Q3 2021 Nov 10, 2021	BUY	$41.23 - $45.88 $672 Million - $747 Million	16,287,048 New	16,287,048 $707 Million

Others Institutions Holding BSX

# of Institutions

1,669

Shares Held

1.18B

Call Options Held

8.76M

Put Options Held

9.42M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $147B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Boston Scientific Corp Transaction History